\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-focal\\ neurological\\ exam\\.\ \(0\)\
\-\ this\\ aneurysm\\ was\\ coiled\\ soon\\ after\\ discovery\\.\\ \\ interval\\ imaging\\ since\\ coiling\\ has\\ confirmed\\ resolution\\ for\\ the\\ past\\ three\\ years\\.\ \(0\)\
\-\ ct\\:\\ \\ there\\ is\\ a\\ berry\\ aneurysm\\ arising\\ from\\ the\\ supraclinoid\\ portion\\ of\\ the\\ left\\ internal\\ carotid\\ artery\\,\\ measuring\\ 16\\ mm\\ ap\\ x\\ 13\\.5\\ mm\\ cc\\ x12\\ mm\\ lat\\ with\\ a\\ 5\\-mm\\ neck\\.\\ the\\ aneurysm\\ projects\\ medially\\ and\\ inferiorly\\ from\\ its\\ origin\\ and\\ encroaches\\ on\\ the\\ optic\\ chiasm\\ and\\ pituitary\\ fossa\\.\\ the\\ pituitary\\ infundibulum\\ may\\ be\\ displaced\\ posteriorly\\.\\ \ \(0\)\
\-\ mr\\:\\ \\ the\\ ventricles\\ are\\ the\\ upper\\ limits\\ of\\ normal\\ in\\ size\\.\\ there\\ is\\ a\\ mixed\\ but\\ primarily\\ hypointense\\ signal\\ foci\\ in\\ the\\ parasellar\\ region\\ to\\ the\\ left\\ of\\ midline\\ superimposed\\ over\\ the\\ sella\\.\\ \\ on\\ t2wi\\ this\\ has\\ a\\ hypointense\\ signal\\ similar\\ to\\ the\\ signal\\ void\\ of\\ the\\ vesicle\\.\\ \\ mr\\ \\(t1w\\-gd\\)\\ shows\\ enhancement\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ mra\\ of\\ the\\ circle\\ of\\ willis\\ shows\\ a\\ flow\\ void\\ component\\ and\\ a\\ central\\ heterogeneous\\ hyperintense\\ signal\\ component\\.\ \(0\)\
\-\ berry\\ aneurysm\ \(8\)\
\-\ \\â\\€\\¢\\ congenital\\ berry\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ atherosclerotic\\ fusiform\\ aneurysm\ \(0\)\
\-\ \\â\\€\\¢\\ mycotic\\ aneurysm\ \(1\)\
\-\ 68\\ y\\.o\\.\\ woman\\ with\\ 6\\ months\\ of\\ daily\\ frontal\\ headaches\\.\ \(1\)\
\-\ saccular\\ \\(berry\\)\\ aneurysms\\ are\\ rounded\\ outpouchings\\ that\\ arise\\ from\\ arterial\\ bifurcation\\ points\\.\\ \\ they\\ most\\ commonly\\ arise\\ secondary\\ to\\ abnormal\\ hemodynamic\\ shear\\ stresses\\,\\ and\\ are\\ not\\ congenital\\ as\\ previously\\ believed\\.\\ \\ berry\\ aneurysms\\ can\\ also\\ be\\ associated\\ with\\ trauma\\,\\ infection\\,\\ tumor\\,\\ drug\\ abuse\\,\\ avm\\,\\ and\\ avf\\.\\ \ \(0\)\
\-\ 15\\-20\\%\\ of\\ cases\\ are\\ multiple\\.\\ \\ they\\ are\\ found\\ in\\ the\\ cow\\ \\/\\ mca\\ bifurcation\\ 90\\%\\ of\\ the\\ time\\.\\ \\ most\\ berry\\ aneurysms\\ become\\ symptomatic\\ between\\ 40\\ and\\ 60\\ years\\ of\\ age\\,\\ commonly\\ presenting\\ with\\ subarachnoid\\ hemorrhage\\,\\ with\\ an\\ associated\\ high\\ mortality\\ and\\ morbidity\\ rate\\.\\ \\ the\\ risk\\ of\\ rupture\\ is\\ 1\\-2\\%\\ annually\\.\\ \\ there\\ is\\ a\\ 20\\-50\\%\\ rebleed\\ risk\\.\\ \\ larger\\ size\\ correlates\\ with\\ increased\\ rupture\\ risk\\,\\ but\\ there\\ is\\ no\\ critical\\ size\\ that\\ can\\ be\\ used\\ to\\ predict\\ risk\\ for\\ bleed\\.\\ \\ when\\ a\\ berry\\ aneurysm\\ is\\ discovered\\,\\ aneurysm\\ obliteration\\ is\\ necessary\\,\\ because\\ of\\ the\\ poor\\ prognosis\\ for\\ subarachnoid\\ hemorrhage\\.\ \(0\)\
\-\ ct\\:\\ \\ in\\ the\\ case\\ of\\ a\\ patent\\ aneurysm\\,\\ a\\ well\\-delineated\\ iso\\/hyperdense\\ lesion\\ that\\ exhibits\\ uniform\\ intense\\ enhancement\\ is\\ demonstrated\\.\\ \\ in\\ the\\ case\\ of\\ a\\ thrombosed\\ aneurysm\\,\\ the\\ residual\\ lumen\\ and\\ outer\\ rim\\ may\\ enhance\\ strongly\\.\\ \\ no\\ enhancement\\ is\\ seen\\ in\\ complete\\ thrombosis\\.\ \(0\)\
\-\ mr\\:\\ \\ appearance\\ can\\ be\\ highly\\ variable\\,\\ secondary\\ to\\ varied\\ flow\\ characteristics\\.\\ \\ patent\\ aneurysms\\ can\\ demonstrate\\ a\\ hyper\\ or\\ hypointense\\ signal\\ depending\\ on\\ flow\\.\\ \\ wall\\ enhancement\\ may\\ occur\\.\\ \\ thrombosed\\ aneurysms\\ demonstrate\\ flow\\ void\\ signal\\ surrounded\\ by\\ concentric\\ layers\\ of\\ clot\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ cebral\\ jr\\,\\ et\\ al\\.\\ characterization\\ of\\ cerebral\\ aneurysms\\ for\\ assessing\\ risk\\ of\\ rupture\\ by\\ using\\ patient\\-specific\\ computational\\ hemodynamics\\ models\\.\\ am\\ j\\ neuroradiol\\.\\ 2005\\;\\ 26\\(10\\)\\:2550\\-9\\.\ \(0\)\
\-\ foutrakis\\ gn\\,\\ yonas\\ h\\,\\ sclabassi\\ rj\\.\\ \\ saccular\\ aneurysm\\ formation\\ in\\ curved\\ and\\ bifurcating\\ arteries\\.\\ am\\ j\\ neuroradiol\\.\\ 1999\\;\\ 20\\(7\\)\\:1309\\-17\\.\ \(0\)\
\-\ osborn\\ ag\\.\\ diagnostic\\ neuroradiology\\.\\ \\ mosby\\,\\ st\\ louis\\,\\ 1994\\.\\ \\ pp\\ 248\\-281\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ berry\\:\\ 0\\.09830731274088138\ \(0\)\
\-\ aneurysm\\:\\ 0\\.07661487595561368\ \(0\)\
\-\ aneurysms\\:\\ 0\\.05814713387356403\ \(0\)\
\-\ void\\:\\ 0\\.030897292593459493\ \(0\)\
\-\ risk\\:\\ 0\\.029255261317193634\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.025972053969418468\ \(0\)\
\-\ signal\\:\\ 0\\.025554718301770647\ \(0\)\
\-\ hypointense\\:\\ 0\\.02298683075142954\ \(0\)\
\-\ saccular\\:\\ 0\\.022401310646768747\ \(0\)\
\-\ thrombosed\\:\\ 0\\.0220029722132798\ \(0\)\
\-\ flow\\:\\ 0\\.021353904550915057\ \(0\)\
\-\ rupture\\:\\ 0\\.020575421274815178\ \(0\)\
\-\ bifurcation\\:\\ 0\\.019677128587229767\ \(0\)\
\-\ mm\\:\\ 0\\.017819632269158822\ \(0\)\
\-\ enhancement\\:\\ 0\\.017319385755183637\ \(0\)\
\-\ x12\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ 5\\-mm\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ t1w\\-gd\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ rebleed\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ well\\-delineated\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ iso\\/hyperdense\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ cebral\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ patient\\-specific\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ computational\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ \\:2550\\-9\\.\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ foutrakis\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ yonas\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ sclabassi\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ \\:1309\\-17\\.\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ 248\\-281\\:\\ 0\\.01666449607555104\ \(0\)\
\-\ am\\:\\ 0\\.016622600439205673\ \(0\)\
\-\ size\\:\\ 0\\.016246933108008156\ \(0\)\
\-\ pituitary\\:\\ 0\\.016192510135399782\ \(0\)\
\-\ arise\\:\\ 0\\.01599452153230974\ \(0\)\
\-\ patent\\:\\ 0\\.015918140786307777\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.015697842456916564\ \(0\)\
\-\ mr\\:\\ 0\\.01539810664619906\ \(0\)\
\-\ hemodynamics\\:\\ 0\\.015354198947838476\ \(0\)\
\-\ models\\:\\ 0\\.015354198947838476\ \(0\)\
\-\ gn\\:\\ 0\\.015354198947838476\ \(0\)\
\-\ bifurcating\\:\\ 0\\.015354198947838476\ \(0\)\
\-\ \\%\\:\\ 0\\.0150723707625407\ \(0\)\
\-\ component\\:\\ 0\\.014755627743782406\ \(0\)\
\-\ can\\:\\ 0\\.014655745576325669\ \(0\)\
\-\ j\\:\\ 0\\.014592405921985775\ \(0\)\
\-\ cow\\:\\ 0\\.014587724263323986\ \(0\)\
\-\ 13\\.5\\:\\ 0\\.014043901820125913\ \(0\)\
\-\ shear\\:\\ 0\\.014043901820125913\ \(0\)\
\-\ supraclinoid\\:\\ 0\\.013277427135611424\ \(0\)\
\-\ 1994\\.\\:\\ 0\\.013277427135611424\ \(0\)\
\-\ parasellar\\:\\ 0\\.012986026984709234\ \(0\)\
\-\ vesicle\\:\\ 0\\.012986026984709234\ \(0\)\
\-\ stresses\\:\\ 0\\.012986026984709234\ \(0\)\
\-\ curved\\:\\ 0\\.012986026984709234\ \(0\)\
\-\ coiling\\:\\ 0\\.01273360469241335\ \(0\)\
\-\ encroaches\\:\\ 0\\.01273360469241335\ \(0\)\
\-\ 20\\-50\\:\\ 0\\.01273360469241335\ \(0\)\
\-\ annually\\:\\ 0\\.012510952451096935\ \(0\)\
\-\ predict\\:\\ 0\\.012510952451096935\ \(0\)\
\-\ varied\\:\\ 0\\.012510952451096935\ \(0\)\
\-\ osborn\\:\\ 0\\.012510952451096935\ \(0\)\
\-\ willis\\:\\ 0\\.012311783234352463\ \(0\)\
\-\ 15\\-20\\:\\ 0\\.012311783234352463\ \(0\)\
\-\ commonly\\:\\ 0\\.012191045154841745\ \(0\)\
\-\ outpouchings\\:\\ 0\\.012131612762132567\ \(0\)\
\-\ coiled\\:\\ 0\\.011967130007898862\ \(0\)\
\-\ lat\\:\\ 0\\.011967130007898862\ \(0\)\
\-\ circle\\:\\ 0\\.011967130007898862\ \(0\)\
\-\ rj\\:\\ 0\\.011967130007898862\ \(0\)\
\-\ non\\-focal\\:\\ 0\\.01181582054159728\ \(0\)\
\-\ characterization\\:\\ 0\\.01181582054159728\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.01181582054159728\ \(0\)\
\-\ congenital\\:\\ 0\\.011815345820954396\ \(0\)\
\-\ infundibulum\\:\\ 0\\.011675729856996673\ \(0\)\
\-\ avf\\:\\ 0\\.011675729856996673\ \(0\)\
\-\ ag\\:\\ 0\\.011675729856996673\ \(0\)\
\-\ they\\:\\ 0\\.011640628077456734\ \(0\)\
\-\ hemodynamic\\:\\ 0\\.011545308549837973\ \(0\)\
\-\ hyper\\:\\ 0\\.011545308549837973\ \(0\)\
\-\ discovery\\:\\ 0\\.011423307564700788\ \(0\)\
\-\ are\\:\\ 0\\.011010150023909279\ \(0\)\
\-\ projects\\:\\ 0\\.0110014861066399\ \(0\)\
\-\ jr\\:\\ 0\\.0110014861066399\ \(0\)\
\-\ assessing\\:\\ 0\\.0110014861066399\ \(0\)\
\-\ louis\\:\\ 0\\.010909255172482183\ \(0\)\
\-\ obliteration\\:\\ 0\\.010821315634420004\ \(0\)\
\-\ exhibits\\:\\ 0\\.010821315634420004\ \(0\)\
\-\ concentric\\:\\ 0\\.010821315634420004\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.010753333021459493\ \(0\)\
\-\ points\\:\\ 0\\.010737285837499715\ \(0\)\
\-\ \\:\\:\\ 0\\.010683126805204774\ \(0\)\
\-\ may\\:\\ 0\\.010629461449327735\ \(0\)\
\-\ st\\:\\ 0\\.010579664648579012\ \(0\)\
\-\ mycotic\\:\\ 0\\.010505523413884717\ \(0\)\
\-\ correlates\\:\\ 0\\.010505523413884717\ \(0\)\
\-\ pp\\:\\ 0\\.010505523413884717\ \(0\)\
\-\ superimposed\\:\\ 0\\.01036543272928411\ \(0\)\
\-\ \\,\\:\\ 0\\.01023478508571975\ \(0\)\
\-\ soon\\:\\ 0\\.010113010436988226\ \(0\)\
\-\ critical\\:\\ 0\\.010054840949905516\ \(0\)\
\-\ layers\\:\\ 0\\.010054840949905516\ \(0\)\
\-\ be\\:\\ 0\\.009964134013942754\ \(0\)\
\-\ morbidity\\:\\ 0\\.009838564293614883\ \(0\)\
\-\ fusiform\\:\\ 0\\.009788151728242179\ \(0\)\
\-\ t2wi\\:\\ 0\\.009691188978927338\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.009691188978927338\ \(0\)\
\-\ believed\\:\\ 0\\.009691188978927338\ \(0\)\
\-\ there\\:\\ 0\\.0096159966462381\ \(0\)\
\-\ chiasm\\:\\ 0\\.009598958044769621\ \(0\)\
\-\ is\\:\\ 0\\.009566383753237298\ \(0\)\
\-\ mosby\\:\\ 0\\.009511018506707443\ \(0\)\
\-\ years\\:\\ 0\\.00948674153882224\ \(0\)\
\-\ uniform\\:\\ 0\\.009468536737610923\ \(0\)\
\-\ clot\\:\\ 0\\.009426988709787152\ \(0\)\
\-\ abuse\\:\\ 0\\.009386334257573611\ \(0\)\
\-\ mca\\:\\ 0\\.009386334257573611\ \(0\)\
\-\ sella\\:\\ 0\\.009307557893867432\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.00926936752086645\ \(0\)\
\-\ bleed\\:\\ 0\\.009231933442801838\ \(0\)\
\-\ surrounded\\:\\ 0\\.009231933442801838\ \(0\)\
\-\ medially\\:\\ 0\\.009195226286172156\ \(0\)\
\-\ 68\\:\\ 0\\.009159218356170845\ \(0\)\
\-\ 1999\\:\\ 0\\.009159218356170845\ \(0\)\
\-\ mra\\:\\ 0\\.009055135601571548\ \(0\)\
\-\ secondary\\:\\ 0\\.009032249400789442\ \(0\)\
\-\ a\\:\\ 0\\.008996592857888876\ \(0\)\
\-\ strongly\\:\\ 0\\.008988800403440604\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.008886659838918079\ \(0\)\
\-\ shows\\:\\ 0\\.008882320225818068\ \(0\)\
\-\ mortality\\:\\ 0\\.008802713309275664\ \(0\)\
\-\ 2005\\:\\ 0\\.008716116832845998\ \(0\)\
\-\ cc\\:\\ 0\\.008660514025272664\ \(0\)\
\-\ variable\\:\\ 0\\.00860650008870545\ \(0\)\
\-\ outer\\:\\ 0\\.00858006106795925\ \(0\)\
\-\ intense\\:\\ 0\\.008553986735005873\ \(0\)\
\-\ h\\:\\ 0\\.008502892836351963\ \(0\)\
\-\ inferiorly\\:\\ 0\\.008477854600529617\ \(0\)\
\-\ primarily\\:\\ 0\\.008477854600529617\ \(0\)\
\-\ depending\\:\\ 0\\.008404670267484834\ \(0\)\
\-\ that\\:\\ 0\\.008370401107138886\ \(0\)\
\-\ daily\\:\\ 0\\.008357408826642834\ \(0\)\
\-\ drug\\:\\ 0\\.008288660917057059\ \(0\)\
\-\ characteristics\\:\\ 0\\.008036238624761176\ \(0\)\
\-\ residual\\:\\ 0\\.008016649235279992\ \(0\)\
\-\ \\/\\:\\ 0\\.007978069137678467\ \(0\)\
\-\ rounded\\:\\ 0\\.007959070393153888\ \(0\)\
\-\ discovered\\:\\ 0\\.007959070393153888\ \(0\)\
\-\ interval\\:\\ 0\\.007921636315089275\ \(0\)\
\-\ enhance\\:\\ 0\\.007813586383444761\ \(0\)\
\-\ larger\\:\\ 0\\.007778899920933992\ \(0\)\
\-\ lumen\\:\\ 0\\.007778899920933992\ \(0\)\
\-\ highly\\:\\ 0\\.007778899920933992\ \(0\)\
\-\ avm\\:\\ 0\\.007694870124013702\ \(0\)\
\-\ become\\:\\ 0\\.007694870124013702\ \(0\)\
\-\ prognosis\\:\\ 0\\.00766227691714318\ \(0\)\
\-\ \\;\\:\\ 0\\.007657547026285799\ \(0\)\
\-\ posteriorly\\:\\ 0\\.007630236164187087\ \(0\)\
\-\ associated\\:\\ 0\\.007623676982637814\ \(0\)\
\-\ 90\\:\\ 0\\.007614417166700288\ \(0\)\
\-\ ventricles\\:\\ 0\\.0075987294487140965\ \(0\)\
\-\ optic\\:\\ 0\\.007477705141029917\ \(0\)\
\-\ 26\\:\\ 0\\.007477705141029917\ \(0\)\
\-\ most\\:\\ 0\\.007458733995191214\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00743460166855592\ \(0\)\
\-\ displaced\\:\\ 0\\.007419979765112939\ \(0\)\
\-\ origin\\:\\ 0\\.007405819705133434\ \(0\)\
\-\ 16\\:\\ 0\\.0073095624453465595\ \(0\)\
\-\ poor\\:\\ 0\\.007269763940246687\ \(0\)\
\-\ carotid\\:\\ 0\\.007243689607293312\ \(0\)\
\-\ from\\:\\ 0\\.007182055084050354\ \(0\)\
\-\ necessary\\:\\ 0\\.007155161630574788\ \(0\)\
\-\ mixed\\:\\ 0\\.007094373139772271\ \(0\)\
\-\ arterial\\:\\ 0\\.007070594723502214\ \(0\)\
\-\ case\\:\\ 0\\.007068069689479285\ \(0\)\
\-\ 60\\:\\ 0\\.007047111698930273\ \(0\)\
\-\ using\\:\\ 0\\.007012425236419504\ \(0\)\
\-\ neurological\\:\\ 0\\.006989649549243371\ \(0\)\
\-\ resolution\\:\\ 0\\.006967145007643526\ \(0\)\
\-\ foci\\:\\ 0\\.006933882697831843\ \(0\)\
\-\ thrombosis\\:\\ 0\\.006933882697831843\ \(0\)\
\-\ but\\:\\ 0\\.006890371648519991\ \(0\)\
\-\ al\\:\\ 0\\.006847942482185799\ \(0\)\
\-\ rim\\:\\ 0\\.006837469551419041\ \(0\)\
\-\ 40\\:\\ 0\\.006796148580128872\ \(0\)\
\-\ previously\\:\\ 0\\.006785957939987329\ \(0\)\
\-\ references\\:\\ 0\\.006716121427337642\ \(0\)\
\-\ hyperintense\\:\\ 0\\.006706352107567429\ \(0\)\
\-\ arising\\:\\ 0\\.006686963638442308\ \(0\)\
\-\ arteries\\:\\ 0\\.006686963638442308\ \(0\)\
\-\ formation\\:\\ 0\\.006667772009965904\ \(0\)\
\-\ limits\\:\\ 0\\.00665824876983366\ \(0\)\
\-\ et\\:\\ 0\\.006611339187376715\ \(0\)\
\-\ fossa\\:\\ 0\\.0065837422130456125\ \(0\)\
\-\ presenting\\:\\ 0\\.0065837422130456125\ \(0\)\
\-\ measuring\\:\\ 0\\.006460029721075134\ \(0\)\
\-\ symptomatic\\:\\ 0\\.006417738042900212\ \(0\)\
\-\ diagnostic\\:\\ 0\\.006401082788302566\ \(0\)\
\-\ similar\\:\\ 0\\.0063358915291888245\ \(0\)\
\-\ rate\\:\\ 0\\.006296259906381556\ \(0\)\
\-\ midline\\:\\ 0\\.006249773322000985\ \(0\)\
\-\ used\\:\\ 0\\.0061969454762721395\ \(0\)\
\-\ 7\\:\\ 0\\.006189517729315827\ \(0\)\
\-\ headaches\\:\\ 0\\.006174749223197123\ \(0\)\
\-\ its\\:\\ 0\\.006095522577420872\ \(0\)\
\-\ confirmed\\:\\ 0\\.006074479400920222\ \(0\)\
\-\ has\\:\\ 0\\.006066918603002941\ \(0\)\
\-\ occur\\:\\ 0\\.006060579638528429\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.00593987742305294\ \(0\)\
\-\ since\\:\\ 0\\.00593339247958075\ \(0\)\
\-\ ap\\:\\ 0\\.005907672910477198\ \(0\)\
\-\ portion\\:\\ 0\\.005851052263438727\ \(0\)\
\-\ 20\\:\\ 0\\.005808157346232544\ \(0\)\
\-\ complete\\:\\ 0\\.005685020669160784\ \(0\)\
\-\ because\\:\\ 0\\.005651263358385724\ \(0\)\
\-\ cerebral\\:\\ 0\\.005596307186699567\ \(0\)\
\-\ in\\:\\ 0\\.005576144822271804\ \(0\)\
\-\ for\\:\\ 0\\.005513105093706731\ \(0\)\
\-\ the\\:\\ 0\\.005488156859690249\ \(0\)\
\-\ \\(\\:\\ 0\\.0054620924479686995\ \(0\)\
\-\ three\\:\\ 0\\.00544541442031552\ \(0\)\
\-\ 10\\:\\ 0\\.00544541442031552\ \(0\)\
\-\ internal\\:\\ 0\\.005415644369336052\ \(0\)\
\-\ \\)\\:\\ 0\\.005395370072690398\ \(0\)\
\-\ cases\\:\\ 0\\.005381495016977566\ \(0\)\
\-\ by\\:\\ 0\\.005379474114347352\ \(0\)\
\-\ x\\:\\ 0\\.005329047892906384\ \(0\)\
\-\ central\\:\\ 0\\.005314993113156823\ \(0\)\
\-\ past\\:\\ 0\\.005132702215399686\ \(0\)\
\-\ between\\:\\ 0\\.005120029369043939\ \(0\)\
\-\ found\\:\\ 0\\.005090785660590004\ \(0\)\
\-\ frontal\\:\\ 0\\.005074275868588577\ \(0\)\
\-\ age\\:\\ 0\\.004916654679667876\ \(0\)\
\-\ 6\\:\\ 0\\.004824423745510159\ \(0\)\
\-\ artery\\:\\ 0\\.0048100755994483916\ \(0\)\
\-\ neck\\:\\ 0\\.00474337076941112\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004739924352470638\ \(0\)\
\-\ infection\\:\\ 0\\.004695683504863529\ \(0\)\
\-\ wall\\:\\ 0\\.004678939735801033\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0046623429727536865\ \(0\)\
\-\ when\\:\\ 0\\.004626335042752374\ \(0\)\
\-\ appearance\\:\\ 0\\.004619861203657168\ \(0\)\
\-\ abnormal\\:\\ 0\\.004606979660330645\ \(0\)\
\-\ region\\:\\ 0\\.004562573208391895\ \(0\)\
\-\ time\\:\\ 0\\.004562573208391895\ \(0\)\
\-\ ct\\:\\ 0\\.004519106440045531\ \(0\)\
\-\ high\\:\\ 0\\.004420691986912695\ \(0\)\
\-\ trauma\\:\\ 0\\.004417785976858089\ \(0\)\
\-\ months\\:\\ 0\\.004411987324555893\ \(0\)\
\-\ over\\:\\ 0\\.0041127459170887766\ \(0\)\
\-\ on\\:\\ 0\\.004105242036098836\ \(0\)\
\-\ to\\:\\ 0\\.0040365605712947665\ \(0\)\
\-\ increased\\:\\ 0\\.003951767073345285\ \(0\)\
\-\ upper\\:\\ 0\\.0038980727889767835\ \(0\)\
\-\ imaging\\:\\ 0\\.003784638609556905\ \(0\)\
\-\ tumor\\:\\ 0\\.003766034596617791\ \(0\)\
\-\ of\\:\\ 0\\.0037439784755497227\ \(0\)\
\-\ woman\\:\\ 0\\.003731385534005494\ \(0\)\
\-\ this\\:\\ 0\\.003633789086253811\ \(0\)\
\-\ left\\:\\ 0\\.0036147647231490163\ \(0\)\
\-\ exam\\:\\ 0\\.0035486463893185977\ \(0\)\
\-\ and\\:\\ 0\\.0034028167435201976\ \(0\)\
\-\ multiple\\:\\ 0\\.0034022797797339677\ \(0\)\
\-\ after\\:\\ 0\\.0033421572828151278\ \(0\)\
\-\ lesion\\:\\ 0\\.0032902745293014266\ \(0\)\
\-\ no\\:\\ 0\\.003253096978086208\ \(0\)\
\-\ seen\\:\\ 0\\.0031921126938897738\ \(0\)\
\-\ also\\:\\ 0\\.003184536093894426\ \(0\)\
\-\ \\.\\:\\ 0\\.002617168067668251\ \(0\)\
\-\ normal\\:\\ 0\\.002532348685442535\ \(0\)\
\-\ as\\:\\ 0\\.0024434357389302983\ \(0\)\
\-\ not\\:\\ 0\\.002334250797243734\ \(0\)\
\-\ an\\:\\ 0\\.0022337710099900377\ \(0\)\
\-\ or\\:\\ 0\\.0018932377107064415\ \(0\)\
\-\ was\\:\\ 0\\.001868199474884096\ \(0\)\
\-\ with\\:\\ 0\\.001327079501964723\ \(0\)\
